Orchid Cellmark’s loss doubles in 3Q (The Star-Ledger) Shares of Orchid Cellmark fell almost 16 percent this morning after the DNA testing firm said its third-quarter loss more than doubled, in part because of sluggish sales in the United Kingdom.The Princeton company posted a loss of almost $1.46... [News Source]